Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Lacosamide: what can be expected from the next new antiepileptic drug
Epilepsy Currents, 09/09/09
Abou–Khalil BW – Results of this trial demonstrated the efficacy and tolerability of adjunctive lacosamide 200 and 400 mg/day and support that lacosamide may be an advantageous option for the treatment of partial–onset seizures in patients with epilepsy.
Related Articles
Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09
Relevance Score: 91%
“It shouldn’t be something that's evil, it should be talked about”: A phenomenological approach to epilepsy and stigma
Seizure - European Journal of Epilepsy, 10/15/09
Relevance Score: 89%
Interictal EEG spikes identify the region of electrographic seizure onset in some, but not all, pediatric epilepsy patients
Epilepsia, 10/01/09
Relevance Score: 89%
Medically intractable epilepsy in Sturge-Weber syndrome is associated with cortical malformation: Implications for surgical therapy
Epilepsia, 10/01/09
Relevance Score: 89%
Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09
Relevance Score: 88%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort
Parkinsonism & Related Disorders, 12/04/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/04/09
Today in Seizure...keeping you current
Receive free subspecialty "5-minute updates" via email
Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09
Prevalence of epileptiform discharges in healthy children—New data from a prospective study using digital EEG
Epilepsia, 12/04/09
Anti-convulsant Activity of Boerhaavia diffusa: Plausible Role of Calcium Channel Antagonism
Evidence-based Complementary and Alternative Medicine , 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


